Publication:
Prognostic significance of serum thymidine kinase activity (TK1) level in patients with metastatic non-small cell lung cancer (NSCLC)

Simple item page
dc.contributor.authorsKorkmaz, T.; Seber, S.; Basaran, G.; Yumuk, P. F.; Dane, F.; Okutur, K.; Kanitez, M.; Kocar, M.; Telli, F.; Demir, G.; Turhal, N. S.
dc.date.accessioned2022-03-10T17:50:46Z
dc.date.accessioned2026-01-11T13:18:22Z
dc.date.available2022-03-10T17:50:46Z
dc.date.issued2011
dc.identifier.doidoiWOS:000208880304389
dc.identifier.eissn1527-7755
dc.identifier.issn0732-183X
dc.identifier.urihttps://hdl.handle.net/11424/221394
dc.identifier.wosWOS:000208880304389
dc.language.isoeng
dc.publisherAMER SOC CLINICAL ONCOLOGY
dc.relation.ispartofJOURNAL OF CLINICAL ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titlePrognostic significance of serum thymidine kinase activity (TK1) level in patients with metastatic non-small cell lung cancer (NSCLC)
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.issue15
oaire.citation.titleJOURNAL OF CLINICAL ONCOLOGY
oaire.citation.volume29

Files

Collections

Araştırma Çıktıları